• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒16型E7对生长停滞信号的消除是由转化所需的序列介导的。

Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.

作者信息

Demers G W, Espling E, Harry J B, Etscheid B G, Galloway D A

机构信息

Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98040, USA.

出版信息

J Virol. 1996 Oct;70(10):6862-9. doi: 10.1128/JVI.70.10.6862-6869.1996.

DOI:10.1128/JVI.70.10.6862-6869.1996
PMID:8794328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190734/
Abstract

Cells arrest in the G1 or G0 phase of the cell cycle in response to a variety of negative growth signals that induce arrest by different molecular pathways. The ability of human papillomavirus (HPV) oncogenes to bypass these signals and allow cells to progress into the S phase probably contributes to the neoplastic potential of the virus. The E7 protein of HPV-16 was able to disrupt the response of epithelial cells to three different negative growth arrest signals: quiescence imposed upon suprabasal epithelial cells, G1 arrest induced by DNA damage, and inhibition of DNA synthesis caused by treatment with transforming growth factor beta. The same set of mutated E7 proteins was able to abrogate all three growth arrest signals. Mutant proteins that failed to abrogate growth arrest signals were transformation deficient and included E7 proteins that bound retinoblastoma protein in vitro. In contrast, HPV-16 E6 was able to bypass only DNA damage-induced G1 arrest, not suprabasal quiescence or transforming growth factor beta-induced arrest. The E6 and E7 proteins from the low-risk virus HPV-6 were not able to bypass any of the growth arrest signals.

摘要

细胞会因多种负性生长信号而停滞在细胞周期的G1期或G0期,这些信号通过不同的分子途径诱导细胞停滞。人乳头瘤病毒(HPV)癌基因绕过这些信号并使细胞进入S期的能力可能有助于该病毒的致瘤潜能。HPV - 16的E7蛋白能够破坏上皮细胞对三种不同负性生长停滞信号的反应:施加于基底上层上皮细胞的静止状态、由DNA损伤诱导的G1期停滞以及用转化生长因子β处理导致的DNA合成抑制。同一组突变的E7蛋白能够消除所有三种生长停滞信号。未能消除生长停滞信号的突变蛋白缺乏转化能力,包括在体外能结合视网膜母细胞瘤蛋白的E7蛋白。相比之下,HPV - 16 E6仅能绕过由DNA损伤诱导的G1期停滞,而不能绕过基底上层静止状态或转化生长因子β诱导的停滞。低风险病毒HPV - 6的E6和E7蛋白不能绕过任何生长停滞信号。

相似文献

1
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.人乳头瘤病毒16型E7对生长停滞信号的消除是由转化所需的序列介导的。
J Virol. 1996 Oct;70(10):6862-9. doi: 10.1128/JVI.70.10.6862-6869.1996.
2
Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.人乳头瘤病毒E7癌蛋白引发的DNA合成对p21介导的细胞周期蛋白E-细胞周期蛋白依赖性激酶2活性抑制具有抗性。
J Virol. 1997 Jul;71(7):5570-8. doi: 10.1128/JVI.71.7.5570-5578.1997.
3
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.人乳头瘤病毒16型E7癌蛋白使视网膜母细胞瘤肿瘤抑制因子和p21均失活,这对于抑制人上皮细胞的细胞周期停滞是必要的。
J Virol. 2002 Oct;76(20):10559-68. doi: 10.1128/jvi.76.20.10559-10568.2002.
4
Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.单独导入人乳头瘤病毒16型E6或E7基因使人正常胚胎成纤维细胞永生化。
Int J Cancer. 2003 Sep 1;106(3):301-9. doi: 10.1002/ijc.11219.
5
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.人乳头瘤病毒16型E7蛋白导致的视网膜母细胞瘤肿瘤抑制因子失稳不足以克服人角质形成细胞中的细胞周期停滞。
J Virol. 2001 Aug;75(15):6737-47. doi: 10.1128/JVI.75.15.6737-6747.2001.
6
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.对表达人乳头瘤病毒16型E7癌蛋白的细胞中p53介导的G1期生长停滞途径的分析。
J Virol. 1997 Apr;71(4):2905-12. doi: 10.1128/JVI.71.4.2905-2912.1997.
7
Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.人乳头瘤病毒E6和E7癌蛋白可改变细胞周期进程,但不会改变低剂量率辐射处理的癌细胞的放射敏感性。
Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):145-54. doi: 10.1016/s0360-3016(96)00448-8.
8
Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.低风险和高风险皮肤乳头瘤病毒E6和E7基因特性的比较显示,低风险1型人乳头瘤病毒的E7蛋白具有很强的转化能力和高Rb结合活性。
J Virol. 1994 Nov;68(11):7051-9. doi: 10.1128/JVI.68.11.7051-7059.1994.
9
Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.人乳头瘤病毒16型E6和E7致癌基因通过p53依赖和p53非依赖途径在体内消除辐射诱导的DNA损伤反应。
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2290-5. doi: 10.1073/pnas.95.5.2290.
10
Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.在宫颈癌细胞中,通过表达针对人乳头瘤病毒转化蛋白的反义E6和E7信使核糖核酸(mRNA)以及视网膜母细胞瘤基因的正义mRNA的转录单位来抑制肿瘤发生。
Cancer Gene Ther. 1995 Mar;2(1):19-32.

引用本文的文献

1
Genome composition-based deep learning predicts oncogenic potential of HPVs.基于基因组组成的深度学习预测 HPV 的致癌潜力。
Front Cell Infect Microbiol. 2024 Jul 22;14:1430424. doi: 10.3389/fcimb.2024.1430424. eCollection 2024.
2
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.一种具有联合预防和治疗活性的安全且增强型多类型HPV L2-E7纳米颗粒疫苗。
NPJ Vaccines. 2024 Jun 26;9(1):119. doi: 10.1038/s41541-024-00914-z.
3
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.CDK4/6 抑制增强了 SHP2 抑制剂的疗效,并且依赖于 RB 功能在恶性外周神经鞘瘤中。
Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876.
4
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制增强了SHP2抑制剂的疗效,并且依赖于恶性外周神经鞘瘤中RB功能的恢复。
bioRxiv. 2023 Feb 3:2023.02.02.526674. doi: 10.1101/2023.02.02.526674.
5
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers.人乳头瘤病毒 42 驱动数字乳头状腺癌,并引发 HPV 阳性癌症中保守的生殖细胞样程序。
Cancer Discov. 2023 Jan 9;13(1):70-84. doi: 10.1158/2159-8290.CD-22-0489.
6
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine.人乳头瘤病毒16/18/58三价治疗性腺病毒载体疫苗的构建及免疫效果
Infect Agent Cancer. 2022 Feb 23;17(1):5. doi: 10.1186/s13027-022-00417-3.
7
Molecular pathways in the development of HPV-induced cervical cancer.人乳头瘤病毒(HPV)诱导的宫颈癌发生发展中的分子通路
EXCLI J. 2021 Feb 12;20:320-337. doi: 10.17179/excli2021-3365. eCollection 2021.
8
Human papillomavirus E6 and E7: What remains?人乳头瘤病毒 E6 和 E7:还有什么?
Tumour Virus Res. 2021 Jun;11:200213. doi: 10.1016/j.tvr.2021.200213. Epub 2021 Feb 8.
9
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.针对人乳头瘤病毒 16(HPV16)和 HPV18 的 E6 和 E7 蛋白的 DNA 疫苗的开发,用于与重组痘苗增强和 PD-1 抗体联合免疫治疗。
mBio. 2021 Jan 19;12(1):e03224-20. doi: 10.1128/mBio.03224-20.
10
KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.KDM6A 介导的长非编码 RNA DINO 的表达导致人乳头瘤病毒 16 E7 表达细胞中 TP53 肿瘤抑制因子的稳定。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.02178-19.

本文引用的文献

1
Regulation of the cyclin E gene by transcription factor E2F1.转录因子E2F1对细胞周期蛋白E基因的调控。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12146-50. doi: 10.1073/pnas.92.26.12146.
2
Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.在表达人乳头瘤病毒E6和E7的成纤维细胞中,细胞周期激酶复合物的改变先于肿瘤转化。
J Virol. 1996 Feb;70(2):999-1008. doi: 10.1128/JVI.70.2.999-1008.1996.
3
Identification of distinct roles for separate E1A domains in disruption of E2F complexes.鉴定E1A不同结构域在破坏E2F复合物中的不同作用。
Mol Cell Biol. 1993 Nov;13(11):7029-35. doi: 10.1128/mcb.13.11.7029-7035.1993.
4
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.人乳头瘤病毒16 E6的表达会破坏p53介导的细胞对DNA损伤的反应。
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92. doi: 10.1073/pnas.90.9.3988.
5
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.16型人乳头瘤病毒E7通过转化所需的序列与组蛋白H1激酶和p107相关联。
J Virol. 1993 May;67(5):2521-8. doi: 10.1128/JVI.67.5.2521-2528.1993.
6
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.p27Kip1是一种细胞周期蛋白依赖性激酶抑制剂,它将转化生长因子-β和接触抑制与细胞周期停滞联系起来。
Genes Dev. 1994 Jan;8(1):9-22. doi: 10.1101/gad.8.1.9.
7
Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene.人乳头瘤病毒16型E7基因永生化的人上皮细胞系中野生型p53蛋白水平升高。
Virology. 1994 Jan;198(1):169-74. doi: 10.1006/viro.1994.1019.
8
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.人乳头瘤病毒16型E6蛋白与E6相关蛋白复合物在p53蛋白的泛素化过程中作为一种泛素蛋白连接酶发挥作用。
Cell. 1993 Nov 5;75(3):495-505. doi: 10.1016/0092-8674(93)90384-3.
9
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.p53 依赖性 G1 期阻滞涉及与 pRB 相关的蛋白质,并被人乳头瘤病毒 16 E7 癌蛋白破坏。
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5320-4. doi: 10.1073/pnas.91.12.5320.
10
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.人乳头瘤病毒16型E7可绕过DNA受损角质形成细胞中由p53诱导的生长停滞。
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4382-6. doi: 10.1073/pnas.91.10.4382.